Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease

Takashi Kuda, Mikio Shoji, Hiroyuki Arai, Seiichi Kawashima, Takaomi C. Saido

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


Previously, we hypothesized that aminopeptidase-catalyzed proteolysis may limit the rate of β-amyloid catabolism in brain and that reduction of a certain aminopeptidase activity may lead to deposition of peptidic metabolites represented by β-amyloid and thus to Alzheimer's disease (AD). To explore this possibility in clinical situations and to seek a possible biochemical marker for the disease, we quantitated four classes of aminopeptidase activities in cerebrospinal fluids and heparinized plasma from sporadic AD patients and age-matched controls collected in two independent medical institutions. We found that only plasma glutamyl aminopeptidase activity was significantly and consistently lower in AD patients. Although the mechanism leading to such a biochemical change in plasma remains to be elucidated, the results provide support for the aminopeptidase hypothesis and indicate that the enzyme activity may potentially be used as a diagnostic/predictive marker for AD.

Original languageEnglish
Pages (from-to)526-530
Number of pages5
JournalBiochemical and biophysical research communications
Issue number3
Publication statusPublished - 1997 Feb 24
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease'. Together they form a unique fingerprint.

Cite this